Showing results (121-130 of 322) with videos related to
Sort By:
Pageof 33
American Journal of Hematology|October 6, 2022
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasmsJürgen Thiele, Hans Michael Kvasnicka, Attilio Orazi, et al.Stem Cells (Dayton, Ohio)|February 16, 2008
Thrombopoietin inhibits murine mast cell differentiationFabrizio Martelli, Barbara Ghinassi, Rodolfo Lorenzini, et al.American Journal of Hematology|April 5, 2012
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPNElisabetta Antonioli, Paola Guglielmelli, Lisa Pieri, et al.American Journal of Hematology|July 22, 2014
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net studyIda Martinelli, Valerio De Stefano, Alessandra Carobbio, et al.Stem Cells (Dayton, Ohio)|May 31, 2008
Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosisCostanza Bogani, Vanessa Ponziani, Paola Guglielmelli, et al.Experimental Hematology|June 30, 2009
JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia veraAlessandra Carobbio, Guido Finazzi, Elisabetta Antonioli, et al.Leukemia & Lymphoma|November 14, 2024
When and how to transplant in myelofibrosis - recent trendsNaman Sharma, Giuseppe G Loscocco, Naseema Gangat, et al.Blood|December 8, 2009
Thrombosis in primary myelofibrosis: incidence and risk factorsTiziano Barbui, Alessandra Carobbio, Francisco Cervantes, et al.Blood|July 1, 2008
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemiaAlessandra Carobbio, Guido Finazzi, Elisabetta Antonioli, et al.Therapeutic Advances in Hematology|November 6, 2023
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosisFrancesco Mannelli, Francesca Crupi, Roberta Zanotti, et al.Pageof 33